Table 4.
3 months |
6 months |
12 months |
||||
---|---|---|---|---|---|---|
Outcomes | Difference between means (95% CI) | P | Difference between means (95% CI) | P | Difference between means (95% CI) | P |
HbA1c (%) | 0.01 (–0.23, 0.26) | 0.92 | –0.06 (–0.32, 0.20) | 0.67 | 0.01 (–0.30, 0.32) | 0.94 |
Cholesterol (mmol/l) | N/A | N/A | –0.12 (–0.34, 0.10) | 0.28 | –0.04 (–0.18, 0.26) | 0.70 |
Triglycerides (mmol/l) | N/A | N/A | –0.28 (–0.64, 0.08) | 0.13 | –0.13 (–0.42, 0.16) | 0.37 |
Severe hypoglycaemia* | N/A | N/A | N/A | N/A | –0.05 (–0.61, 0.50) | 0.85 |
Body mass index (kg/m2) | –0.01 (–0.35, 0.33) | 0.96 | –0.07 (–0.48, 0.34) | 0.74 | 0.07 (–0.56, 0.42) | 0.77 |
Total daily insulin dose (units) | 0.33 (–2.17, 2.84) | 0.79 | 2.33 (–0.46, 5.11) | 0.10 | 0.29 (–3.30, 3.88) | 0.87 |
Fifty-four patients in intervention group and 60 patients in the control group.
Severe episodes per annum.